The entry of antiviral and antiretroviral drugs into the central nervous system

References

• Agrawal S. Prospects for Antisense Nucleic: Acid Therapy of Cancer and AIDS. Prospects for Antisense Nucleic Acid Therapy of Cancer and AIDS, E Wickstrom. Wiley-Liss, New York 1991; 142–158
   Google Scholar
• Agrawal Temsamani S. J. Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice. Proc Natl Acad Sci USA 1991; 88: 7595–7599
   Google Scholar
• Anderson B D, Hoesterey BL. Uptake kinetics of 2 3-dideoxyinosine into brain and cerebrospinal fluid of rats; intravenous infusion studies. J Pharmacol Exp Titer 1990; 253: 113–118
   Google Scholar
• Archer D P, Labrecque P. Cerebral blood volume is increased in dogs during administration of nitrous oxide or isoflurance. Anesthesiology 1987; 67: 642–648
   Google Scholar
• Artru A A. Reduction of cerebrospinal pressure by hypocapnia: changes in cerebral blood volume, cerebrospinal fluid volume, and brain tissue water and electrolytes. J Cereb Blood Flow Metab 1987; 7: 471–479
   Google Scholar
• Betz A, Goldstein L. GW. Blood-Brain-Cerebrospinal Fluid Barriers. Basic Neuro-chemistry: Molecular, Cellular and Medical Aspects, GJ Siegel. Raven Press, New York 1994; 681–699
   Google Scholar
• Blasberg R G. Methotrexate, cytosine arabinoside, and BCNU concentration in brain after ventri-culocisternal perfusion. Cancer Treat Rep 1977; 61: 625–631
   PubMedGoogle Scholar
• Blasberg R G, Groothuis D R. Chemotherapy of brain tumors: physiological and pharmacokinetic considerations. Sem Oncol 1986; 13: 70–83
   PubMed Web of Science ®Google Scholar
• Blasberg R G, Patlak C. Intrathecal chemotherapy: brain tissue profiles after ventriculo-cisternal perfusion. J Pharmacol Exp Ther 1975; 195: 78–83
   Google Scholar
• Blasberg R G, Patlak CS. Distribution of methotrexate in the cerebrospinal fluid and brain after intraventricular administration. Cancer Treat Rep 1977; 61: 633–641
   PubMedGoogle Scholar
• Blasberg R G, Patlak CS. Selection of experimental conditions for the accurate determination of blood-brain transfer constants from single-time experiments: a theoretical analysis. J Cereb Blood Flow Metab 1983a; 3: 215–225
   Google Scholar
• Blasberg R G, Patlak CS. The transport of alpha-aminoisobutyric acid across brain capillary and cellular membranes. J Cereb Blood Flow Metab 1983b; 3: 8–32
   PubMed Web of Science ®Google Scholar
• Boado R J. Antisense drug delivery through the blood-brain barrier. Advanced Drug Deliv Rev 1995; 15: 73–107
   Web of Science ®Google Scholar
• Boado R J, Kang Y-S. Rapid plasma clearance and metabolism in vivo of a phosphorothioate oligodeoxynucleotide with a single, internal phosphodiester bond. Drug Metab Disp 1995; 23: 1297–1300
   Google Scholar
• Bobo R H, Laske DW. Convection enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci USA 1994; 91: 2076–2080
   PubMed Web of Science ®Google Scholar
• Boschi G, Launay N. Brain microdialysis in the mouse. J Pharmacol Toxicol Meth 1995; 33: 29–33
   PubMed Web of Science ®Google Scholar
• Bradbury M. The Concept of a Blood-Brain Barrier. J. Wiley, New York 1979
   Google Scholar
• Bradbury M WB. Physiology and Pharmacology of the Blood-Brain Barrier. Springer Verlag, Berlin 1992
   Google Scholar
• Bradley W G. Magnetic resonance imaging in the evaluation of cerebrospinal fluid flow abnormalities. Magn Meson Quart 1992; 8: 169–196
   PubMedGoogle Scholar
• Brewster M E, Pop E. The effect of dihydronicontinate N-substitution on the brain targeting efficacy of a zidovudine chemical delivery system. Pharm Res 1993; 10: 1356–1362
   Google Scholar
• Budinger T F, Huesman R H. Ten precepts for quantitative data acquisition and analysis. Circulation 1985; 72: 53–62, (Suppl 4)
   Google Scholar
• Burger DM, Meenhorst PL. Concise overview of the clinical pharmacokinetics of dideoxynucleoside antiretroviral agents. Pharm World Sci 1995; 17: 25–30
   Google Scholar
• Chem T-L, Miller PS. Disposition and metabolism of oligodeoxynucleoside methylphosphonate following a single iv injection into mice. Drug Metab Disp 1990; 18: 815–818
   PubMed Web of Science ®Google Scholar
• Chlasson B J, Hong M. Antisense therapeutics in the central nervous system: the induction of c-fos. Antisense Therapeutics, S Agrawal. Humana Press, Totowa, N.J. 1996; 225–246
   Google Scholar
• Chu C K, Bhadti VS. Brain targeting of anti-HIV nucleosides: synthesis and in vitro and in vivo studies of hihydropyridine derivatives of 3′-azido-2′,2′-dideoxyuridine and 3′-azido-3′-dideoxythymidine. J Med Chem 1990; 33: 2188–2192
   PubMed Web of Science ®Google Scholar
• Cohn S E, Nawaz T. Antiviral Agents. A Practical Approach to Infectious Diseases, RE Reese, RF Betts. Little, Brown and Co., Boston 1996; 967–1036
   Google Scholar
• Collins J M, Dedrick R L. Distributed model for drug delivery to CSF and brain tissue. Am J Physiol 1983; 14: R303–R310
   Google Scholar
• Cornford E M, Oldendorf W H. Independent blood-brain barrier transport systems for nucleic acid precursors. Biochim Biophys Acta 1975; 394: 211–219
   PubMedGoogle Scholar
• Cossum P A, Sasmor H. Disposition of the 14C-labeled phosphorothioate oligonucleotide ISIS 2105 after intravenous administration to rats. J Pharmacol Exp Ther 1993; 267: 1181–1190
   PubMed Web of Science ®Google Scholar
• Cremer J E, Seville M P. Regional brain blood flow, blood volume and hematocrit values in the adult rat. J Cereb Blood Flow Metab 1983; 3: 254–256
   PubMed Web of Science ®Google Scholar
• Crone C. The permeability of capillaries in various organs as determined by the use of the ‘indicator diffusion’ method. Acta Physiol Scand 1963; 59: 292–305
   Google Scholar
• Crooke S T, Graham MJ. Pharmacokinetic properties of several novel oligonucleotide analogs in mice. J Pharmacol Exp Ther 1996; 277: 923–937
   PubMed Web of Science ®Google Scholar
• Cserr H F, Cooper DN. Flow of cerebral interstitial fluid as indicated by the removal of extracellular markers from rat caudate nucleus. Exp Eye Res 1977; 25: 461–473, (Suppl)
   Google Scholar
• Cserr H F, Cooper DN. Efflux of radiolabeled polyethylene glycols and albumin from rat brain. Am J Physiol 1981; 240: F319–F328
   PubMed Web of Science ®Google Scholar
• Davis S S. Biomedical applications of nanotechnology-implications for drug targeting and gene therapy. TIBTECH 1997; 15: 217–224
   PubMed Web of Science ®Google Scholar
• Davson H, Segal M B. Physiology of the CSF and Blood-Brain Barriers. CRC Press, Boca Raton 1996
   Google Scholar
• De Lange E C, Hesselink MB. The use of intracerebral microdialysis to determine changes in blood-brain barrier transport characteristics. Pharm Res 1995; 12: 129–133
   PubMed Web of Science ®Google Scholar
• Denissen J F, Grabowski BA. Metabolism and disposition of the HIV-1 protease inhibitor ritonavir (ABT-538) in rats, dogs, and humans. Drug Metab Disp 1997; 25: 489–501
   PubMed Web of Science ®Google Scholar
• Dudley M N. Clinical pharmacokinetics of nucleoside antiretroviral agents. J Infect Dis 1995; 171: S99–112
   PubMedGoogle Scholar
• Dykstra K H, Arya A. Microdialysis study of zidovudine (AZT) transport in rat brain. J Pharm Exp Ther 1993; 267: 1227–1236
   PubMed Web of Science ®Google Scholar
• Fenstermacher J D. Pharmacology of the blood-brain barrier. Implications of the Blood-Brain Barrier and Its Manipulation, KA Neuwelt. Plenum Medical Book Co, New York 1989; 137–155
   Google Scholar
• Fenstermacher J D, Blasberg RG. Methods for quantifying the transport of drugs across brain barrier systems. Pharmacology and Therapeutics 1981; 14: 217–248
   PubMed Web of Science ®Google Scholar
• Fenstermacher J D, Rail DP. Ventri culocisternal perfusion as a technique for analysis of brain capillary permeability and extra-cellular transport. Capillary Permeability, C Crone, NA Lassen. Academic Press, New York 1970; 484–490
   Google Scholar
• Fink D J, DeLuca NA. Gene transfer to neurons using herpes simplex virus-based vectors. Ann Bev Neurosci 1996; 19: 265–287
   PubMed Web of Science ®Google Scholar
• Fishman R A. Cerebrospinal Fluid in Diseases of the Nervous System. W.B. Saunders Co, Philadelphia 1980
   Google Scholar
• Flexner C, Hendrix C. Pharmacology of antiretroviral agents. AIDS: Biology, Diagnosis. Treatment and Prevention, VT DeVitn, S. Hellman, SA Roxenberg. Lippincott-Raven, Philadelphia 1997; 479–493
   Google Scholar
• Galinsky R E, Hoesterey BL. Brain and cerebrospinal fluid uptake of zidovudine (AZT) in rats after intravenous injection. Life Sci 1990; 47: 781–788
   Google Scholar
• Gallo J M. Pharmacokinetic models for anticancer and antiviral drugs following administrations as novel drug delivery systems. Advanced Methods of Pharmacokinetic and Pharmacodynamic Systems Analysis, DZ D'Argenio. Plenum Press, New York 1991; 21–36
   Google Scholar
• Gallo J M. Delivery of anti-HIV nucleosides to the central nervous system. Advanced Drug Deliv Rev 1994; 14: 299–309
   Google Scholar
• Ghersi Egea J F, Finnegan W. Rapid distribution of intraventricularly administered sucrose into cerebrospinal fluid cisterns via subarachnoid velae in rat. Neuroscience 1996; 75: 1271–1288
   Google Scholar
• Greenwald R B. Drug delivery systems: anticancer prodrugs and their polymeric conjugates. Exp Opin Ther Patents 1997; 7: 601–609
   Web of Science ®Google Scholar
• Greitz D. Cerebrospinal fluid circulation and associated intracranial dynamics. Acta Radiol 1993; 34: 1–23, (Suppl)
   Google Scholar
• Iversen P L, Copple BL. Pharmacology and toxicology of phosphorothioate oligonucleotides in the mouse, rat, monkey and man. Toxicol Letters 1995; 82/83: 425–430
   Google Scholar
• Kang Y-S, Boado RJ. Pharmacokinetics and organ clearance of a 3′-biotinylated, internally [32P]-labeled phosphodiester oligonucleotide coupled to a neutral avidin/monoclonal antibody conjugate. Drug Metab Disp 1995; 23: 55–59
   PubMed Web of Science ®Google Scholar
• Kessler J A, Fenstermacher JD. Spinal subarachnoid perfusion of rhesus monkeys. Am J Physiol 1976; 230: 614–618
   Google Scholar
• Kimberlin D W, Spector SA. Assays for antiviral drug resistance. Antiviral Res 1995; 26: 403–413
   PubMedGoogle Scholar
• Kuhl D E, Alavi A. Local cerebral blood volume in head-injured patients. J Neurosurg 1980; 52: 309–320
   Google Scholar
• Levin V A, Gilboe D D. Blood volume, hematocrit and pressure relationship in the isolated perfused dog brain. Stroke 1970; 1: 270–277
   Google Scholar
• Levy K M, Ward S. Alternative delivery systems for antiviral nucleosides and antisense oligonucleotides to the brain. J Neurovirol 1997; 3: S74–S75
   Google Scholar
• Lin J H, Chiba M. Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor. Drug Metab Disp 1996; 1111–1120
   Google Scholar
• Lu D, Raizada M K. Delivery of angiotensin II type 1 receptor antisense inhibits angiotensin action in neurons from hypertensive rat brain. Proc Natl Acad Sci USA 1995; 92: 2914–2918
   Google Scholar
• Masereeuw R, Jaehde U. In vitro and in vivo transport of zidovudine (AZT) across the blood brain barrier and the effect of transport inhibitors. Pharm Res 1994; 11: 324–330
   PubMed Web of Science ®Google Scholar
• McCarthy M M, Nielsen DA. Antisense oligonucleotide inhibition of tryptophan hydroxylase activity in mouse brain. Regulatory Peptides 1995; 59: 163–170
   Google Scholar
• McCarthy M M, Schlenker EH. Enduring consequences of neonatal treatment with antisense oligodeoxynucleotides to estrogen receptor messenger ribonucleic acid on sexual differentiation of rat brain. Endocrinology 1993; 133: 433–439
   PubMed Web of Science ®Google Scholar
• Milhorat T H. The third circulation revisited. J Neurosurg 1975; 42: 628–645
   PubMed Web of Science ®Google Scholar
• Morgan M E, Singhal D. Quantitative assessment of blood-brain barrier damage during microdialysis. J Pharmacol Exp Ther 1996; 277: 1167–1176
   PubMed Web of Science ®Google Scholar
• Morrison P F, Laske DW. High flow microinfusion: tissue penetration and pharmacodynamics. Am J Physiol 1994; 266: R292–305
   PubMed Web of Science ®Google Scholar
• Nakagawa H, Groothuis DR. Dexamethasone effects on vascular volume and tissue hematocrit in experimental RG-2 gliomas and adjacent brain. J Neurooncol 1988; 6: 157–168
   Google Scholar
• Nau R, Zysk G. Pharmacokinetic quantification of the exchange of drugs between blood and cerebrospinal fluid in man. Europ J Clin Pharmacol 1993; 45: 469–475
   Google Scholar
• Ohno K, Pettigrew KD. Lower limits of cerebrovascular permeability to nonelectrolytes in the conscious rat. Am J Physiol 1978; 235: H299–H307
   PubMed Web of Science ®Google Scholar
• Oldendorf W H. Measurement of brain uptake of radiolabeled substances using a tritiated water internal standard. Brain Res 1970; 24: 372–376
   PubMedGoogle Scholar
• Parsons L H, Justice J B. Quantitative approaches to in vivo brain microdialysis. Critical Rev Neurobiol 1994; 8: 189–220
   Google Scholar
• Patlak C S, Fenstermacher J D. Measurements of dog blood-brain transfer constants by ventri-culocisternal perfusion. Am J Physiol 1975; 229: 877–884
   Google Scholar
• Patlak C S, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983; 3: 1–7
   PubMed Web of Science ®Google Scholar
• Rapoport S I. Blood-Brain Barrier in Physiology and Medicine. Raven Press, New York 1976
   Google Scholar
• Rapoport S I, Fitzhugh R. Drug entry into and distribution within brain and cerebrospinal fluid: [14C]urea pharmacokinetics. Am J Physiol 1982; 242: R339–R348
   Google Scholar
• Rapoport S I. Passage of proteins from blood to cerebrospinal fluid. Model for transfer by pores and vesicles. Neurobiology of Cerebrospinal Fluid, JH Wood. Plenum Press, New York 1983; 233–246
   Google Scholar
• Renkin E M. Transport of potassium-42 from blood to tissue in isolated mammalian skeletal muscle. Am J Physiol 1959; 197: 1205–1210
   PubMed Web of Science ®Google Scholar
• Robinson P J, Rapoport S I. Model for drug uptake by brain tumors: effect of osmotic treatment and of diffusion in brain. J Cereb Blood Flow Metab 1990; 10: 153–161
   PubMed Web of Science ®Google Scholar
• Rosenberg G A, Kyner WT. Bulk flow of brain interstitial fluid under normal and hyperosmolar conditions. Am J Physiol 1980; 238: F42–F49
   PubMed Web of Science ®Google Scholar
• Saijo Y, Perlaky L. Pharmacokinetics, tissue distribution, and stability of antisense oligonucleotide phosphorothioate ISIS 3466 in mice. Oncol Res 1994; 6: 243–249
   PubMed Web of Science ®Google Scholar
• Sakai F, Nakazawa K. Regional cerebral blood volume and hematocrit measured in normal human volunteers by single-photon emission computed tomography. J Cereb Blood Flow Metab 1985; 5: 207–213
   Google Scholar
• Sakai R R, He PF. Intracerebroventricular administration of ATI receptor antisense oligonucleotides inhibits the behavioral actions of angiotensin II. J Neurochem 1994; 62: 2053–2056
   Google Scholar
• Sakai R R, Ma LY. Intracerebroventricular administration of angiotensin type 1 (AT1) receptor antisense oligonucleotides attenuate thirst in the rat. Regulatory Peptides 1995; 59: 183–192
   Google Scholar
• Silverstein H (1996) Poster Presentation. International Conference on AIDS. 1996. Vancouver, BC
   Google Scholar
• Spector R, Spector AZ. Model for transport in the CNS. Am J Physiol 1977; 232: R73–R79
   Google Scholar
• Spector K. Thymidine transport in the CNS. J Neurochem 1980; 35: 1092–1098
   Google Scholar
• Spector R. Pharmacokinetics and metabolism of cytosine arabinoside in the central nervous system. J Pharmacol Exp Ther 1982; 222: 1–6
   Google Scholar
• Spector R, Eells J. Deoxynucleoside and vitamin transport into the central nervous system. Fed Proc 1984; 43: 196–200
   PubMedGoogle Scholar
• Spector R. Thymidine transport and metabolism in choroid plexus: effect of diazepam and thiopental. J Pharmacol Exp Ther 1985a; 235: 16–19
   Google Scholar
• Spector R. Uridine transport and metabolism in the central nervous system. J Neurochem 1985b; 45: 1411–1418
   PubMed Web of Science ®Google Scholar
• Stable L. Microdialysis in pharmacokinetics. Europ J Drug Metab Pharmacokin 1993; 18: 89–96
   Google Scholar
• Szklarczyk A, Kaczmarek L. Antisense oligodeoxyribonucleotides: stability and distribution after intracerebral injection into rat brain. J Neurosci Methods 1995; 60: 181–187
   PubMed Web of Science ®Google Scholar
• Takasawa K, Terasaki T. In vivo evidence for carrier-mediated efflux transport of 3′-azido-3′- deoxythyniidin.fi and 2′, 3′-dideoxyinosine across the blood-brain barrier via a probenecid-sensitive transport system. J Pharmacol Exp Ther 1997; 369–375
   Google Scholar
• Terasaki T, Pardridge W M. Restricted transport of 3-azido-3′-deoxythymidine and dideoxynucleosides through the blood-brain barrier. J Infect Dis 1988; 158: 630–632
   PubMed Web of Science ®Google Scholar
• Walker W L, Cook J. Drug delivery to brain tumors. Bull Mathemat Biol 1996; 58: 1047–1074
   PubMed Web of Science ®Google Scholar
• Wang L, Morin KW. In vivo biodistribution, pharmacokinetic parameters, and brain uptake of 5-halo-y-methnxy (or ethoxy)-5,6-dihydro-3′-azido-3′-deoxythymidine diastereomers as potential prodrugs of 3-azido-3′-deoxythymidine. J Med Chem 1996; 826–833
   Google Scholar
• Wang Y, Sawchuk R J. Zidovudine transport in the rabbit brain during intravenous and intra-cerebroventricular infusion. J Pharm Sci 1995; 84: 871–876
   PubMed Web of Science ®Google Scholar
• West M L, Fairlie D P. Targeting HIV-1 protease: a test of drug-design methodologies. Trend in Pharm Sci 1995; 16: 67–75
   PubMed Web of Science ®Google Scholar
• Westergren I, Nystrom B. Intracerebral dialysis and the blood brain barrier. J Neurochem 1995; 64: 229–234
   PubMed Web of Science ®Google Scholar
• Whitesell L, Geselowitz D. Stability. clearance, and disposition of intraventricularly administered oligodeoxynucleotides: Implications for therapeutic application with the central nervous system. Proc. Natl Acad Sci USA 1993; 90: 4665–4669
   PubMed Web of Science ®Google Scholar
• Wong S L, Van Belle K. Distributional transport kinetics of zidovudine between plasma and brain extracellular fluid/cerebrospinal fluid in the rabbit: investigation of the inhibitory effect of probenecid utilizing microdialysis. J Pharm Exp Ther 1993; 264: 899–909
   PubMed Web of Science ®Google Scholar
• Wood J H. Neurobiology of Cerebrospinal Fluid. Plenum Press, New York 1980
   Google Scholar
• Wu D, Boado RJ. Pharmacokinetics and blood-brain barrier transport of [3H]-biotinylated phosphorothioate oligodeoxynucleotide conjugated In a vector-mediated drug delivery system. J Pharmacol Exp Ther 1996; 276: 206–211
   PubMed Web of Science ®Google Scholar
• Yaida Y, Nowak T S. Distribution of phosphodiester and phosphorothioate oligonucleotides in rat brain after intraventricular and intrahippocampal administration determined by in situ hybridization. Regulatory Peptides 1995; 59: 193–199
   PubMedGoogle Scholar
• Yasdanian M. Poster Presentation. Fourth Conference on Retroviruses and Opportunistic Infections, Washington, DC, 1997
   Google Scholar